Tesamorelin Dosage
Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.
Applies to the following strengths: 1 mg; 2 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Lipodystrophy
2 mg subcutaneously once a day
Comments:
- Long term cardiovascular safety and benefit have not been studied.
- Not indicated for weight loss (weight neutral effect).
- There are no data to support improved compliance with anti-retroviral therapies in HIV positive patients.
Use(s): Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head trauma
- Active malignancy (newly diagnosed or recurrent)
- Hypersensitivity to tesamorelin and/or mannitol (an excipient)
- Pregnancy
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Administer into abdominal skin subcutaneously, rotating sites.
- Do not inject into scar tissue, bruises, or the navel.
More about tesamorelin
- Check interactions
- Compare alternatives
- Reviews (21)
- Side effects
- During pregnancy
- Drug class: growth hormones
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.